Stock listing
Adial Pharmaceuticals, Inc
Selected listing: ADIL · NASDAQ · USD · US
Adial Pharmaceuticals, Inc (NASDAQ:ADIL), Health Technology. Latest release Sep 30, 2026: Adial Pharmaceuticals Announces Inducement Grant under Nasdaq…
- Ticker
- NASDAQ:ADIL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Adial Pharmaceuticals, Inc
Adial Pharmaceuticals, Inc. is a public company traded under the ticker ADIL in the American market. Adial focuses on developing innovative therapies for addiction and related disorders.
Latest news from Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
September 29, 2026
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
August 25, 2026
Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing
June 16, 2026
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
June 11, 2026
Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update
May 11, 2026
Research Adial Pharmaceuticals, Inc
Adial Pharmaceuticals, Inc company profile
View the public company page for Adial Pharmaceuticals, Inc on 6ix.
Adial Pharmaceuticals, Inc news
Read company news and market updates connected to Adial Pharmaceuticals, Inc.
Adial Pharmaceuticals, Inc investor events
Find investor webinars, events, and replay context for Adial Pharmaceuticals, Inc.